Trastuzumab Monoclonal Antibody from Germany
Trastuzumab is a humanized monoclonal antibody that inhibits HER2 protein and is used in HER2-positive breast cancer therapy. As an unmixed bulk product not in measured doses or retail packaging, it is classifiable under tariff item 3002.13.00.
Duty Rate — Germany → Canada
0%
Import Tips
• Verify the product is not dissolved in any solvent or mixed with stabilizers to retain the unmixed classification
• Provide a certificate of analysis to CBSA confirming the product's purity and biotechnological origin
• Confirm whether a Canadian importer's licence is required under the Food and Drug Regulations